EX-23 3 cyt-ex23_1.htm EX-23.1 EX-23

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

1. Registration Statement (Form S-8, No. 333-257920) pertaining to the 2021 Equity Incentive Plan and the 2021 Employee Stock Purchase Plan of Cyteir Therapeutics, Inc.,

 

2. Registration Statement (Form S-8, No. 333-263607) pertaining to the 2021 Equity Incentive Plan of Cyteir Therapeutics, Inc., and

 

3. Registration Statement (Form S-3, No. 333-266676) and related Prospectus of Cyteir Therapeutics, Inc. for the registration of common stock, preferred stock, debt securities, warrants and units;

 

of our report dated March 23, 2023, with respect to the consolidated financial statements of Cyteir Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2022.

 

/s/ Ernst & Young LLP

 

Boston, Massachusetts

March 23, 2023